Critical factors influencing stable transduction of human CD34+ cells with HIV-1-derived lentiviral vectors

Molecular Therapy

Volumn 2, Issue 1, 2000, Pages 71-80

  Haas, Dennis L ^a   Case, Scott S ^b   Crooks, Gay M ^b   Kohn, Donald B ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

CD34; Gene therapy; Hematopoietic stem cells; Lentiviral vector; Transduction

Indexed keywords

HUMAN HERPESVIRUS 5; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLONEY MURINE LEUKEMIA VIRUS; MURINAE; VESICULAR STOMATITIS VIRUS;

CD34 ANTIGEN; FIBRONECTIN; G PROTEIN, VESICULAR STOMATITIS VIRUS; GREEN FLUORESCENT PROTEIN; HEPARIN ANTAGONIST; MEMBRANE PROTEIN; PHOTOPROTEIN; PROTAMINE; VIRUS ENVELOPE PROTEIN;

ARTICLE; CELL LINE; CELL SEPARATION; CYTOLOGY; CYTOMEGALOVIRUS; FETUS BLOOD; FLOW CYTOMETRY; GENE TRANSFER; GENE VECTOR; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; GENETICS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRINAE; METABOLISM; PLASMID; PROMOTER REGION; TIME;

ANTIGENS, CD34; CELL LINE; CELL SEPARATION; CYTOMEGALOVIRUS; FETAL BLOOD; FIBRONECTINS; FLOW CYTOMETRY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HEMATOPOIETIC STEM CELLS; HEPARIN ANTAGONISTS; HIV-1; HUMANS; LENTIVIRUS; LUMINESCENT PROTEINS; MEMBRANE GLYCOPROTEINS; PLASMIDS; PROMOTER REGIONS (GENETICS); PROTAMINES; TIME FACTORS; TRANSDUCTION, GENETIC; TRANSFECTION; VIRAL ENVELOPE PROTEINS;

EID: 0034222871     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1006/mthe.2000.0094     Document Type: Article

References (42)

1. Jones, R. J., Wagner, J. E., Celano, P., Zicha, M. S., and Sharkis, S. J. (1990). Separation of pluripotent haematopoietic stem cells from spleen colony-forming cells [see comments]. Nature 347: 188-189.
2. Hao, Q. L., Thiemann, F. T., Petersen, D., Smogorzewska, E. M., and Crooks, G. M. (1996). Extended long-term culture reveals a highly quiescent and primitive human hematopoietic progenitor population. Blood 88: 3306-3313.
3. Ploemacher, R. E., van der Sluijs, J. P., van Beurden, C. A., Baert, M. R., and Chan, P. L. (1991). Use of limiting-dilution type long-term marrow cultures in frequency analysis of marrow-repopulating and spleen colony-forming hematopoietic stem cells in the mouse. Blood 78: 2527-2533.
4. Ploemacher, R. E., van der Sluijs, J. P., Voerman, J. S., and Brons, N. H. (1989). An in vitro limiting-dilution assay of long-term repopulating hematopoietic stem cells in the mouse. Blood 74: 2755-2763.
5. Traycoff, C. M., Kosak, S. T., Grigsby, S., and Srour, E. F. (1995). Evaluation of ex vivo expansion potential of cord blood and bone marrow hematopoietic progenitor cells using cell tracking and limiting dilution analysis. Blood 85: 2059-2068.
6. Bodine, D. M., Crosier, P. S., and Clark, S. C. (1991). Effects of hematopoietic growth factors on the survival of primitive stem cells in liquid suspension culture. Blood 78: 914-920.
7. Gothot, A., van der Loo, J. C., Clapp, D. W., and Srour, E. F. (1998). Cell cycle-related changes in repopulating capacity of human mobilized peripheral blood CD34(+) cells in non-obese diabetic/severe combined immune-deficient mice. Blood 92: 2641-2649.
8. Harrison, D. E., Lerner, C. P., and Spooncer, E. (1987). Erythropoietic repopulating ability of stem cells from long-term marrow culture. Blood 69: 1021-1025.
9. Larochelle, A., et al. (1996). Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy. Nat. Med. 2: 1329-1337.
10. Peters, S. O., Kittler, E. L., Ramshaw, H. S., and Quesenberry, P. J. (1996). Ex vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL-6, IL-11, and stem cell factor leads to impaired engraftment in irradiated hosts. Blood 87: 30-37.
11. Tisdale, J. F., et al. (1998). Ex vivo expansion of genetically marked rhesus peripheral blood progenitor cells results in diminished long-term repopulating ability. Blood 92: 1131-1141.
12. Akkina, R. K., Walton, R. M., Chen, M. L., Li, Q. X., Planelles, V., and Chen, I. S. (1996). High-efficiency gene transfer into CD34+ cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G. J. Virol. 70: 2581-2585.
13. Blömer, U., Naldini, L., Kafri, T., Trono, D., Verma, I. M., and Gage, F. H. (1997). Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. J. Virol. 71: 6641-6649.
14. Dull, T., et al. (1998). A third-generation lentivirus vector with a conditional packaging system. J. Virol. 72: 8463-8471.
15. Naldini, L., et al. (1996). In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector [see comments]. Science 272: 263-267.
16. Naldini, L., Blömer, U., Gage, F. H., Trono, D., and Verma, I. M. (1996). Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. USA 93: 11382-11388.
17. Sutton, R. E., Wu, H. T., Rigg, R., Böhnlein, E., and Brown, P. O. (1998). Human immunodeficiency virus type 1 vectors efficiently transduce human hematopoietic stem cells. J. Virol. 72: 5781-5788.
18. Uchida, N., et al. (1998). HIV, but not murine leukemia virus, vectors mediate high efficiency gene transfer into freshly isolated G0/G1 human hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 95: 11939-11944.
19. Zufferey, R., Nagy, D., Mandel, R. J., Naldini, L., and Trono, D. (1997). Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat. Biotechnol. 15: 871-875.
20. Case, S. S., et al. (1999). Stable transduction of quiescent CD34+CD38-human hematopoietic cells by HIV-1-based lentiviral vectors. Proc. Natl. Acad. Sci. USA 96: 2988-2993.
21. Gallay, P., Swingler, S., Song, J., Bushman, F., and Trono, D. (1995). HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase. Cell 83: 569-576.
22. Miyoshi, H., Smith, K. A., Mosier, D. E., Verma, I. M., and Torbett, B. E. (1999). Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science 283: 682-686.
23. Crooks, G. M., and Kohn, D. B. (1993). Growth factors increase amphotropic retrovirus binding to human CD34+ bone marrow progenitor cells. Blood 82: 3290-3297.
24. Orlic, D., Girard, L. J., Jordan, C. T., Anderson, S. M., Cline, A. P., and Bodine, D. M. (1996). The level of mRNA encoding the amphotropic retrovirus receptor in mouse and human hematopoietic stem cells is low and correlates with the efficiency of retrovirus transduction. Proc. Natl. Acad. Sci. USA 93: 11097-11102.
25. Mastromarino, P., Conti, C., Goldoni, P., Hauttecoeur, B., and Orsi, N. (1987). Characterization of membrane components of the erythrocyte involved in vesicular stomatitis virus attachment and fusion at acidic pH. J. Gen. Virol. 68(Pt. 9): 2359-2369.
26. Burns, J. C., Friedmann, T., Driever, W., Burrascano, M., and Yee, J. K. (1993). Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: Concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells [see comments]. Proc. Natl. Acad. Sci. USA 90: 8033-8037.
27. Moritz, T., Patel, V. P., and Williams, D. A. (1994). Bone marrow extracellular matrix molecules improve gene transfer into human hematopoietic cells via retroviral vectors. J. Clin. Invest. 93: 1451-1457.
28. Moritz, T., et al. (1996). Fibronectin improves transduction of reconstituting hematopoietic stem cells by retroviral vectors: Evidence of direct viral binding to chymotryptic carboxy-terminal fragments. Blood 88: 855-862.
29. Robbins, P. B., Skelton, D. C., Yu, X. J., Halene, S., Leonard, E. H., and Kohn, D. B. (1998). Consistent, persistent expression from modified retroviral vectors in murine hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 95: 10182-10187.
30. Soneoka, Y., et al. (1995). A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res. 23: 628-633.
31. Liu, M. L., Winther, B. L., and Kay, M. A. (1996). Pseudotransduction of hepatocytes by using concentrated pseudotyped vesicular stomatitis virus G glycoprotein (VSV-G)-Moloney murine leukemia virus-derived retrovirus vectors: Comparison of VSV-G and amphotropic vectors for hepatic gene transfer. J. Virol. 70: 2497-2502.
32. Hao, Q. L., Shah, A. J., Thiemann, F. T., Smogorzewska, E. M., and Crooks, G. M. (1995). A functional comparison of CD34+CD38-cells in cord blood and bone marrow. Blood 86: 3745-3753.
33. Chalfie, M., Tu, Y., Euskirchen, G., Ward, W. W., and Prasher, D. C. (1994). Green fluorescent protein as a marker for gene expression. Science 263: 802-805.
34. Li, X., et al. (1998). Generation of destabilized green fluorescent protein as a transcription reporter. J. Biol. Chem. 273: 34970-34975.
35. Hanenberg, H., Hashino, K., Konishi, H., Hock, R. A., Kato, I., and Williams, D. A. (1997). Optimization of fibronectin-assisted retroviral gene transfer into human CD34+ hematopoietic cells. Hum. Gene Ther. 8: 2193-2206.
36. Gallardo, H. F., Tan, C., Ory, D., and Sadelain, M. (1997). Recombinant retroviruses pseudotyped with the vesicular stomatitis virus G glycoprotein mediate both stable gene transfer and pseudotransduction in human peripheral blood lymphocytes. Blood 90: 952-957.
37. Chuck, A. S., Clarke, M. F., and Palsson, B. O. (1996). Retroviral infection is limited by brownian motion. Hum. Gene Ther. 7: 1527-1534.
38. Morgan, J. R., LeDoux, J. M., Snow, R. G., Tompkins, R. G., and Yarmush, M. L. (1995). Retrovirus infection: Effect of time and target cell number. J. Virol. 69: 6994-7000.
39. Yokota, T., et al. (1998). Growth-supporting activities of fibronectin on hematopoietic stem/progenitor cells in vitro and in vivo: Structural requirement for fibronectin activities of CS1 and cell-binding domains. Blood 91: 3263-3272.
40. Dao, M. A., Hashino, K., Kato, I., and Nolta, J. A. (1998). Adhesion to fibronectin maintains regenerative capacity during ex vivo culture and transduction of human hematopoietic stem and progenitor cells. Blood 92: 4612-4621.
41. Conti, C., Mastromarino, P., Riccioli, A., and Orsi, N. (1991). Electrostatic interactions in the early events of VSV infection. Res. Virol. 142: 17-24.
42. Sutton, R. E., Reitsma, M. J., Uchida, N., and Brown, P. O. (1999). Transduction of human progenitor hematopoietic stem cells by human immunodeficiency virus type 1-based vectors is cell cycle dependent. J. Virol. 73: 3649-3660.